Click for best price
MetagenomicsHealthcare Market Size, Share 2023
Metagenomics is the study of genetic material recovered directly from environmental samples.
This report aims to provide a comprehensive presentation of the global market for Metagenomics in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomics in Healthcare. This report contains market size and forecasts of Metagenomics in Healthcare in global, including the following market information:
Global Metagenomics in Healthcare Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Metagenomics in Healthcare market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sample Extraction Kits Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Metagenomics in Healthcare include Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific and Oxford Nanopore Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Metagenomics in Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metagenomics in Healthcare Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Metagenomics in Healthcare Market Segment Percentages, by Type, 2022 (%)
Sample Extraction Kits
Metagenomics Kits
Global Metagenomics in Healthcare Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Metagenomics in Healthcare Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
Global Metagenomics in Healthcare Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Metagenomics in Healthcare Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metagenomics in Healthcare revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metagenomics in Healthcare revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metagenomics in Healthcare, market overview.
Chapter 2: Global Metagenomics in Healthcare market size in revenue.
Chapter 3: Detailed analysis of Metagenomics in Healthcare company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metagenomics in Healthcare in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Metagenomics in Healthcare Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Metagenomics in Healthcare Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metagenomics in Healthcare Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metagenomics in Healthcare Overall Market Size
2.1 Global Metagenomics in Healthcare Market Size: 2022 VS 2029
2.2 Global Metagenomics in Healthcare Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metagenomics in Healthcare Players in Global Market
3.2 Top Global Metagenomics in Healthcare Companies Ranked by Revenue
3.3 Global Metagenomics in Healthcare Revenue by Companies
3.4 Top 3 and Top 5 Metagenomics in Healthcare Companies in Global Market, by Revenue in 2022
3.5 Global Companies Metagenomics in Healthcare Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metagenomics in Healthcare Players in Global Market
3.6.1 List of Global Tier 1 Metagenomics in Healthcare Companies
3.6.2 List of Global Tier 2 and Tier 3 Metagenomics in Healthcare Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Metagenomics in Healthcare Market Size Markets, 2022 & 2029
4.1.2 Sample Extraction Kits
4.1.3 Metagenomics Kits
4.2 By Type - Global Metagenomics in Healthcare Revenue & Forecasts
4.2.1 By Type - Global Metagenomics in Healthcare Revenue, 2018-2023
4.2.2 By Type - Global Metagenomics in Healthcare Revenue, 2024-2029
4.2.3 By Type - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metagenomics in Healthcare Market Size, 2022 & 2029
5.1.2 Pharmaceutical Industries
5.1.3 Biotechnology Companies
5.1.4 Pathology Laboratories
5.1.5 Academic and Research Laboratories
5.1.6 Others
5.2 By Application - Global Metagenomics in Healthcare Revenue & Forecasts
5.2.1 By Application - Global Metagenomics in Healthcare Revenue, 2018-2023
5.2.2 By Application - Global Metagenomics in Healthcare Revenue, 2024-2029
5.2.3 By Application - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Metagenomics in Healthcare Market Size, 2022 & 2029
6.2 By Region - Global Metagenomics in Healthcare Revenue & Forecasts
6.2.1 By Region - Global Metagenomics in Healthcare Revenue, 2018-2023
6.2.2 By Region - Global Metagenomics in Healthcare Revenue, 2024-2029
6.2.3 By Region - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Metagenomics in Healthcare Revenue, 2018-2029
6.3.2 US Metagenomics in Healthcare Market Size, 2018-2029
6.3.3 Canada Metagenomics in Healthcare Market Size, 2018-2029
6.3.4 Mexico Metagenomics in Healthcare Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Metagenomics in Healthcare Revenue, 2018-2029
6.4.2 Germany Metagenomics in Healthcare Market Size, 2018-2029
6.4.3 France Metagenomics in Healthcare Market Size, 2018-2029
6.4.4 U.K. Metagenomics in Healthcare Market Size, 2018-2029
6.4.5 Italy Metagenomics in Healthcare Market Size, 2018-2029
6.4.6 Russia Metagenomics in Healthcare Market Size, 2018-2029
6.4.7 Nordic Countries Metagenomics in Healthcare Market Size, 2018-2029
6.4.8 Benelux Metagenomics in Healthcare Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Metagenomics in Healthcare Revenue, 2018-2029
6.5.2 China Metagenomics in Healthcare Market Size, 2018-2029
6.5.3 Japan Metagenomics in Healthcare Market Size, 2018-2029
6.5.4 South Korea Metagenomics in Healthcare Market Size, 2018-2029
6.5.5 Southeast Asia Metagenomics in Healthcare Market Size, 2018-2029
6.5.6 India Metagenomics in Healthcare Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Metagenomics in Healthcare Revenue, 2018-2029
6.6.2 Brazil Metagenomics in Healthcare Market Size, 2018-2029
6.6.3 Argentina Metagenomics in Healthcare Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metagenomics in Healthcare Revenue, 2018-2029
6.7.2 Turkey Metagenomics in Healthcare Market Size, 2018-2029
6.7.3 Israel Metagenomics in Healthcare Market Size, 2018-2029
6.7.4 Saudi Arabia Metagenomics in Healthcare Market Size, 2018-2029
6.7.5 UAE Metagenomics in Healthcare Market Size, 2018-2029
7 Metagenomics in Healthcare Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Metagenomics in Healthcare Major Product Offerings
7.1.4 Illumina Metagenomics in Healthcare Revenue in Global Market (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 QIAGEN
7.2.1 QIAGEN Company Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Metagenomics in Healthcare Major Product Offerings
7.2.4 QIAGEN Metagenomics in Healthcare Revenue in Global Market (2018-2023)
7.2.5 QIAGEN Key News & Latest Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Company Summary
7.3.2 PerkinElmer Business Overview
7.3.3 PerkinElmer Metagenomics in Healthcare Major Product Offerings
7.3.4 PerkinElmer Metagenomics in Healthcare Revenue in Global Market (2018-2023)
7.3.5 PerkinElmer Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Major Product Offerings
7.4.4 Thermo Fisher Scientific Metagenomics in Healthcare Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Oxford Nanopore Technologies
7.5.1 Oxford Nanopore Technologies Company Summary
7.5.2 Oxford Nanopore Technologies Business Overview
7.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Major Product Offerings
7.5.4 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue in Global Market (2018-2023)
7.5.5 Oxford Nanopore Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Metagenomics in Healthcare Market Opportunities & Trends in Global Market
Table 2. Metagenomics in Healthcare Market Drivers in Global Market
Table 3. Metagenomics in Healthcare Market Restraints in Global Market
Table 4. Key Players of Metagenomics in Healthcare in Global Market
Table 5. Top Metagenomics in Healthcare Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Metagenomics in Healthcare Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Metagenomics in Healthcare Revenue Share by Companies, 2018-2023
Table 8. Global Companies Metagenomics in Healthcare Product Type
Table 9. List of Global Tier 1 Metagenomics in Healthcare Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metagenomics in Healthcare Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Metagenomics in Healthcare Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Metagenomics in Healthcare Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Metagenomics in Healthcare Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Metagenomics in Healthcare Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Metagenomics in Healthcare Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Metagenomics in Healthcare Revenue, (US$, Mn), 2024-2029
Table 30. Illumina Company Summary
Table 31. Illumina Metagenomics in Healthcare Product Offerings
Table 32. Illumina Metagenomics in Healthcare Revenue (US$, Mn) & (2018-2023)
Table 33. Illumina Key News & Latest Developments
Table 34. QIAGEN Company Summary
Table 35. QIAGEN Metagenomics in Healthcare Product Offerings
Table 36. QIAGEN Metagenomics in Healthcare Revenue (US$, Mn) & (2018-2023)
Table 37. QIAGEN Key News & Latest Developments
Table 38. PerkinElmer Company Summary
Table 39. PerkinElmer Metagenomics in Healthcare Product Offerings
Table 40. PerkinElmer Metagenomics in Healthcare Revenue (US$, Mn) & (2018-2023)
Table 41. PerkinElmer Key News & Latest Developments
Table 42. Thermo Fisher Scientific Company Summary
Table 43. Thermo Fisher Scientific Metagenomics in Healthcare Product Offerings
Table 44. Thermo Fisher Scientific Metagenomics in Healthcare Revenue (US$, Mn) & (2018-2023)
Table 45. Thermo Fisher Scientific Key News & Latest Developments
Table 46. Oxford Nanopore Technologies Company Summary
Table 47. Oxford Nanopore Technologies Metagenomics in Healthcare Product Offerings
Table 48. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue (US$, Mn) & (2018-2023)
Table 49. Oxford Nanopore Technologies Key News & Latest Developments
List of Figures
Figure 1. Metagenomics in Healthcare Segment by Type in 2022
Figure 2. Metagenomics in Healthcare Segment by Application in 2022
Figure 3. Global Metagenomics in Healthcare Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metagenomics in Healthcare Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Metagenomics in Healthcare Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metagenomics in Healthcare Revenue in 2022
Figure 8. By Type - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 9. By Application - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 10. By Type - Global Metagenomics in Healthcare Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 12. By Application - Global Metagenomics in Healthcare Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 14. By Region - Global Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 15. By Country - North America Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 16. US Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 20. Germany Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 21. France Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 28. China Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 32. India Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 34. Brazil Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Metagenomics in Healthcare Revenue Market Share, 2018-2029
Figure 37. Turkey Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Metagenomics in Healthcare Revenue, (US$, Mn), 2018-2029
Figure 41. Illumina Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. QIAGEN Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PerkinElmer Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Thermo Fisher Scientific Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
